In the first of a two-part investigation, Cannabiz editor-at-large Rhys Cohen analyses the TGA’s handling of medicinal cannabis advertising complaints and explains why the body is struggling to keep up.
Since 2018, the Therapeutic Goods Administration (TGA) has received more than 450 complaints regarding advertising of medicinal cannabis. As of September 21, 2020, only 202 of those cases had been resolved.
Not only that, but of a sample of 96 medicinal cannabis advertising complaints completed since 2018, the TGA missed their time-to-action performance target in more than 50% of cases (more on that shortly).
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.